InsidersTradesSigma
Total declarations
Company
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
14
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-17.5%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by KATZ MICHAEL W, Executive. Director active across 1 company, notably Organogenesis Holdings Inc.. Aggregated, 14 disclosures have been logged. Breakdown: 14 buys · 0 sell. Total volume traded: €408k. Activity tracked since 17 August 2021. The latest transaction was filed on 18 November 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
3,000 shares@ US$2.571.8% of flowClass A Common StockSEC:0001062993-22-022671:0
Canonical exit: 16 Feb 2023 (T+90)
4,000 shares@ US$5.98520.0035% mcap5.7% of flowClass A Common StockSEC:0001062993-22-012917:0
Canonical exit: 14 Aug 2022 (T+90)
500 shares@ US$9.650.0006% mcap1.1% of flowClass A Common StockSEC:0001062993-21-012871:0
Canonical exit: 13 Mar 2022 (T+90)
500 shares@ US$9.651.0% of flowClass A Common StockSEC:0001062993-21-012871
Canonical exit: 13 Mar 2022 (T+90)
1,000 shares@ US$9.750.0013% mcap2.1% of flowClass A Common StockSEC:0001062993-21-012263:0
Canonical exit: 2 Mar 2022 (T+90)
1,000 shares@ US$9.752.1% of flowClass A Common StockSEC:0001062993-21-012263
Canonical exit: 2 Mar 2022 (T+90)
1,000 shares@ US$9.750.0013% mcap2.2% of flowClass A Common StockSEC:0001062993-21-011910:0
Canonical exit: 27 Feb 2022 (T+90)
1,000 shares@ US$9.752.1% of flowClass A Common StockSEC:0001062993-21-011910
Canonical exit: 27 Feb 2022 (T+90)
1,000 shares@ US$9.822.1% of flowClass A Common StockSEC:0001062993-21-011825
Canonical exit: 24 Feb 2022 (T+90)
1,000 shares@ US$9.820.0013% mcap2.2% of flowClass A Common StockSEC:0001062993-21-011825:0
Canonical exit: 24 Feb 2022 (T+90)
2,000 shares@ US$11.304.8% of flowClass A Common StockSEC:0001661181-21-000071
Canonical exit: 10 Feb 2022 (T+90)
2,000 shares@ US$11.300.0030% mcap4.9% of flowClass A Common StockSEC:0001661181-21-000071:0
Canonical exit: 10 Feb 2022 (T+90)
12,000 shares@ US$13.550.021% mcap34.7% of flowClass A Common StockSEC:0001661181-21-000066:0
Canonical exit: 15 Nov 2021 (T+90)
12,000 shares@ US$13.5534.0% of flowClass A Common StockSEC:0001661181-21-000066
Canonical exit: 15 Nov 2021 (T+90)
14 of 14 declarations
About KATZ MICHAEL W
KATZ MICHAEL W is an executive at Organogenesis Holdings Inc. In this role, he contributes to managing the company's operations and implementing its strategy. His expertise is valuable for supporting Organogenesis Holdings Inc.'s initiatives.
